Sonoma Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Sonoma Pharmaceuticals, Inc. (SNOA)
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.sonomapharma.com
Company Research
Source: Yahoo! Finance
Net loss: US$866.0k (loss narrowed by 55% from 3Q 2023). US$0.079 loss per share (improved from US$0.62 loss in 3Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period Sonoma Pharmaceuticals EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 17%. Earnings per share (EPS) exceeded analyst estimates by 62%. Looking ahead, revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 8.9% growth forecast for the Pharmaceuticals industry in the US. Performance of the American Pharmaceuticals industry. The company's shares are down 3.2% from a week ago. Risk Analysis You still need to take note of risks, for example - Sonoma Pharmaceuticals has 4 warning signs (and 3 which are potentially serious) we think you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This
Show less
Read more
Impact Snapshot
Event Time:
SNOA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNOA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNOA alerts
High impacting Sonoma Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
SNOA
News
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesAccesswire
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections [Yahoo! Finance]Yahoo! Finance
- Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections Accesswire
- Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences [Yahoo! Finance]Yahoo! Finance
SNOA
Sec Filings
- 4/9/24 - Form 8-K
- 4/2/24 - Form 8-K
- 3/22/24 - Form 8-K
- SNOA's page on the SEC website